Cocrystal Pharma (COCP) Invested Capital (2010 - 2022)
Cocrystal Pharma (COCP) posted Invested Capital of $21000.0 for Q2 2022, down 25.0% sequentially from $28000.0 in Q1 2022, and down 61.11% YoY from $54000.0 in Q2 2021.
Cocrystal Pharma (COCP) Invested Capital (2010 - 2022) Analysis & Trends
Cocrystal Pharma has reported Invested Capital for 9 years, with the latest figure at $21000.0 in Q2 2022.
- Quarterly Invested Capital fell 61.11% year-over-year to $21000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $21000.0 (down 83.2% YoY) and the FY2020 annual result came in at $74000.0, down 36.75% from the prior year.
- Invested Capital fell to $21000.0 in Q2 2022 per COCP's latest filing, from $28000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $341000.0 in Q4 2018 and troughed at $21000.0 in Q2 2022.
- A 5-year average of $118142.9 and a median of $79000.0 in 2020 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2020 and 2021: Invested Capital plunged 78.49% in 2020, then advanced 5.0% in 2021.
- Over 5 years, Invested Capital stood at $341000.0 in 2018, then tumbled by 65.69% to $117000.0 in 2019, then plunged by 36.75% to $74000.0 in 2020, then sank by 41.89% to $43000.0 in 2021, then slumped by 51.16% to $21000.0 in 2022.
- According to Business Quant data, Invested Capital over the past three periods registered $21000.0, $28000.0, and $43000.0 for Q2 2022, Q1 2022, and Q3 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Sep 30, 2021 | 43,000.00 |
| Jun 30, 2021 | 54,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Sep 30, 2020 | 84,000.00 |
| Jun 30, 2020 | 93,000.00 |
| Mar 31, 2020 | 60,000.00 |
| Dec 31, 2019 | 117,000.00 |
| Sep 30, 2019 | 172,000.00 |
| Jun 30, 2019 | 225,000.00 |
| Mar 31, 2019 | 279,000.00 |
| Dec 31, 2018 | 341,000.00 |
| Jun 30, 2013 | 206,042.00 |
| Mar 31, 2013 | 206,040.00 |
| Dec 31, 2012 | 181,752.00 |
| Sep 30, 2012 | 194,247.00 |
| Jun 30, 2012 | 217,755.00 |
| Mar 31, 2012 | 241,149.00 |